AAAAAA
Results:
1-16
|
Results: 16
Authors:
Benedit, P
Paciucci, R
Thomson, TM
Valeri, M
Nadal, M
Caceres, C
de Torres, I
Estivill, X
Lozano, JJ
Morote, J
Reventos, J
Citation: P. Benedit et al., PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks, ONCOGENE, 20(12), 2001, pp. 1455-1464
Authors:
Morote, J
Citation: J. Morote, Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage free serum prostate-specific antigen - Reply, BJU INT, 86(1), 2000, pp. 147-147
Authors:
Morote, J
Encabo, G
de Torres, IM
Citation: J. Morote et al., Use of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancer, EUR UROL, 38(2), 2000, pp. 225-229
Authors:
Morote, J
Encabo, G
Lopez, M
de Torres, IM
Citation: J. Morote et al., Prediction of prostate volume based on total and free serum prostate-specific antigen: Is it reliable?, EUR UROL, 38(1), 2000, pp. 91-95
Authors:
Morote, J
Lopez, M
Encabo, G
de Torres, IM
Citation: J. Morote et al., Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen, EUR UROL, 37(5), 2000, pp. 537-540
Authors:
Morote, J
Raventos, CX
Encabo, G
Lopez, M
de Torres, IM
Citation: J. Morote et al., Effect of high-grade prostatic intraepithelial neoplasia on total and percent free serum prostatic-specific antigen, EUR UROL, 37(4), 2000, pp. 456-459
Authors:
Martinez, E
Morote, J
Citation: E. Martinez et J. Morote, Tumor markers in bladder cancer, MED CLIN, 114(10), 2000, pp. 378-379
Authors:
Vila, MR
Nicolas, A
Morote, J
de Torres, I
Meseguer, A
Citation: Mr. Vila et al., Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction, CANCER, 89(1), 2000, pp. 152-164
Authors:
Morote, J
Encabo, G
Lopez, M
de Torres, IM
Citation: J. Morote et al., Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage fi ee serum prostatic specific antigen, BJU INT, 84(6), 1999, pp. 657-660
Authors:
Morote, J
Encabo, G
Lopez, MA
de Torres, IM
Citation: J. Morote et al., The free-to-total serum prostatic specific antigen ratio as a predictor ofthe pathological features of prostate cancer, BJU INT, 83(9), 1999, pp. 1003-1006
Authors:
Morote, J
Encabo, G
Lopez, M
De Torres, IM
Citation: J. Morote et al., Individual variations of total and percent free serum prostatic specific antigen: Could they change the indication of prostatic biopsy?, ONCOL REP, 6(4), 1999, pp. 887-890
Authors:
Schwartz, S
Caceres, C
Morote, J
De Torres, I
Rodriguez-Vallejo, JM
Gonzalez, J
Reventos, J
Citation: S. Schwartz et al., Gains of the relative genomic content of erbB-1 and erbB-2 in prostate carcinoma and their association with metastasis, INT J ONCOL, 14(2), 1999, pp. 367-371
Authors:
Lorente, JA
Valenzuela, H
Morote, J
Gelabert, A
Citation: Ja. Lorente et al., Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients, EUR J NUCL, 26(6), 1999, pp. 625-632
Authors:
Morote, J
Raventos, CX
Lorente, JA
Enbabo, G
Lopez, M
de Torres, I
Citation: J. Morote et al., Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination, EUR UROL, 36(2), 1999, pp. 111-115
Authors:
Morote, J
Lopez, M
Encabo, G
de Torres, I
Citation: J. Morote et al., Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time, EUR UROL, 35(4), 1999, pp. 294-297
Authors:
Morote, J
de Torres, I
Caceres, C
Vallejo, C
Schwartz, S
Reventos, J
Citation: J. Morote et al., Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer, INT J CANC, 84(4), 1999, pp. 421-425
Risultati:
1-16
|